View in EDS PDF Full Text

Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritis.

Saved in:
Bibliographic Details
Title: Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritis.
Authors: Burmester, Gerd1 (AUTHOR) gerd.burmester@charite.de, Drescher, Edit2 (AUTHOR), Hrycaj, Pawel3 (AUTHOR), Chien, David4 (AUTHOR), Pan, Zhiying4 (AUTHOR), Cohen, Stanley5 (AUTHOR)
Source: Clinical Rheumatology. Nov2020, Vol. 39 Issue 11, p3341-3352. 12p.
Database: Academic Search Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 146479830
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Burmester%2C+Gerd%22">Burmester, Gerd</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> gerd.burmester@charite.de</i><br /><searchLink fieldCode="AR" term="%22Drescher%2C+Edit%22">Drescher, Edit</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hrycaj%2C+Pawel%22">Hrycaj, Pawel</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chien%2C+David%22">Chien, David</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pan%2C+Zhiying%22">Pan, Zhiying</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cohen%2C+Stanley%22">Cohen, Stanley</searchLink><relatesTo>5</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Clinical+Rheumatology%22">Clinical Rheumatology</searchLink>. Nov2020, Vol. 39 Issue 11, p3341-3352. 12p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=146479830
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10067-020-05305-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 3341
    Titles:
      – TitleFull: Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Burmester, Gerd
      – PersonEntity:
          Name:
            NameFull: Drescher, Edit
      – PersonEntity:
          Name:
            NameFull: Hrycaj, Pawel
      – PersonEntity:
          Name:
            NameFull: Chien, David
      – PersonEntity:
          Name:
            NameFull: Pan, Zhiying
      – PersonEntity:
          Name:
            NameFull: Cohen, Stanley
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: Nov2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 07703198
          Numbering:
            – Type: volume
              Value: 39
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Clinical Rheumatology
              Type: main
ResultId 1